Paradigm Biopharmaceuticals Limited
PBIGF
$0.2083
$0.00633.12%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.33M | 17.18M | 11.92M | 11.65M | 22.87M |
| Total Receivables | 3.94M | 4.42M | 3.39M | 3.31M | 5.06M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 704.60K | 789.40K | 869.80K | 850.10K | 579.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 19.98M | 22.39M | 16.18M | 15.82M | 28.51M |
|
|
|||||
| Total Current Assets | 19.98M | 22.39M | 16.18M | 15.82M | 28.51M |
| Net Property, Plant & Equipment | 73.10K | 81.90K | 126.50K | 123.70K | 179.30K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.82M | 2.04M | 1.97M | 1.92M | 2.01M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 21.88M | 24.51M | 18.27M | 17.86M | 30.70M |
|
|
|||||
| Total Accounts Payable | 359.50K | 402.70K | 1.88M | 1.84M | 6.81M |
| Total Accrued Expenses | 256.70K | 287.50K | 278.10K | 271.80K | 560.70K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 50.40K | 56.40K | 81.30K | 79.50K | 77.20K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 666.50K | 746.70K | 2.24M | 2.19M | 7.45M |
|
|
|||||
| Total Current Liabilities | 666.50K | 746.70K | 2.24M | 2.19M | 7.45M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 61.90K | 69.30K | 78.40K | 76.60K | 120.70K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 77.10K | 86.40K | 71.40K | 69.80K | 95.50K |
| Total Liabilities | 805.50K | 902.50K | 2.39M | 2.34M | 7.66M |
|
|
|||||
| Common Stock & APIC | 156.71M | 175.58M | 158.87M | 155.27M | 162.31M |
| Retained Earnings | -138.14M | -154.76M | -147.27M | -143.94M | -144.35M |
| Treasury Stock & Other | 2.50M | 2.80M | 4.29M | 4.19M | 5.07M |
| Total Common Equity | 21.08M | 23.61M | 15.88M | 15.52M | 23.04M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 21.08M | 23.61M | 15.88M | 15.52M | 23.04M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 21.08M | 23.61M | 15.88M | 15.52M | 23.04M |
|
|
|||||